Author

Christian Scheurer

Swiss Tropical and Public Health InstituteORCID 0000-0002-1777-0867Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 1 Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 1 Organism:mouse· 1 Organism:plant (other)· 1 Assay:proteomics· 1

Frequent Co-Authors

Till Steffen VossiD· 2 shared Amr Hamed Mahmoud· 1 shared Armand Guiguemde· 1 shared Armin PasseckeriD· 1 shared Arne AlderiD· 1 shared Basil T. ThommeniD· 1 shared Charisse Flerida A. PasajeiD· 1 shared Christin GumppiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Till Steffen VossORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Molecular BiologybioRxivPreprintSep 13, 2026

A high-throughput compound screen identifies multiple druggable targets in Plasmodium falciparum transmission stages

Leonie Seefeldt, Christin Gumpp, Olivia Carril…·Nicolas M. B. Brancucci

This study identifies three druggable targets in Plasmodium falciparum gametocytes using high-throughput screening and reveals resistance mechanisms for one compound.

DOI 10.64898/2026.09.10.747198

plant (other)experimental assay

MicrobiologyACS Chemical BiologyPeer-reviewedJun 13, 2026

The Human Chk1 Inhibitor CHIR-124 Shows Multistage Activity Against the Human Malaria Parasite Plasmodium falciparum via Polypharmacological Inhibition of PfArk1 and Hemozoin Formation

Kathryn J. Wicht, John G. Woodland, Larnelle F. Garnie…·Kelly Chibale

This study shows that CHIR-124, a human Chk1 inhibitor, is active against Plasmodium falciparum through dual inhibition of PfArk1 and hemozoin formation, suggesting polypharmacology as a strategy for antimalarial drugs.

5 citationstop 1%

humanmouse